Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
Tapan Behl, Dapinder Kaur, Aayush Sehgal, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3724-3724
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
Karolina Wojtunik‐Kulesza, Monika Rudkowska, Anna Orzeł-Sajdłowska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4367-4367
Open Access | Times Cited: 43
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 17
The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies
P Bailo, Elena Llorente Martín, Pilar Calmarza, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2022) Vol. 3, Iss. 4, pp. 342-350
Open Access | Times Cited: 43
Diet and lifestyle impact the development and progression of Alzheimer’s dementia
Sarah Arora, José A. Santiago, Melissa Bernstein, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 34
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
Donia E. Hafez, Mariam Dubiel, Gabriella La Spada, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Type-B monoamine oxidase inhibitors in neurological diseases
Marika Alborghetti, Edoardo Bianchini, Lanfranco De Carolis, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 16-21
Open Access | Times Cited: 26
Amygdala activity and amygdala-hippocampus connectivity: Metabolic diseases, dementia, and neuropsychiatric issues
Juhyun Song
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114647-114647
Open Access | Times Cited: 24
Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Rudolf Vrabec, Gerald Blunden, Lucie Cahlíková
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4399-4399
Open Access | Times Cited: 23
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease
Zdeněk Fišar, Jana Hroudová
Antioxidants (2024) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 11
Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 679-692
Closed Access | Times Cited: 10
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 9
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 9
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Drug Repurposing using Artificial Intelligence, Molecular Docking, and Hybrid Approaches: A Comprehensive Review in General Diseases vs Alzheimer's Disease
Natasha Azeelen Zulhafiz, Teoh Teik Toe, Ai‐Vyrn Chin, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 261, pp. 108604-108604
Closed Access | Times Cited: 1
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 35
Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies
Cem Yamalı, Halise İnci Gül, Mehtap Tuğrak Sakarya, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105822-105822
Closed Access | Times Cited: 28
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 17
The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Hugo Fanlo-Ucar, Pol Picón-Pagès, Víctor Herrera-Fernández, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1208-1208
Open Access | Times Cited: 7
Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
Daniel C. Xu, Hanna Sas–Nowosielska, Greg Donahue, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes
Sonia Dhiman, Ashi Mannan, Ayushi Taneja, et al.
Life Sciences (2024) Vol. 342, pp. 122537-122537
Closed Access | Times Cited: 6
A Universal and Programmable Platform based on Fluorescent Peptide‐Conjugated Probes for Detection of Proteins in Organelles of Living Cells
Xia Wu, Jingjing Hu, Chong Duan, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 17
Closed Access | Times Cited: 5
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Marcin Cieślak, Tomasz Danel, Olga Krzysztyńska‐Kuleta, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
Slobodan Rendić, Rachel D. Crouch, F. Peter Guengerich
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2145-2246
Open Access | Times Cited: 25
Design, synthesis, spectroscopic characterizations,in vitropancreatic lipase as well as tyrosinase inhibition evaluations andin silicoanalysis of novel aryl sulfonate-naphthalene hybrids
Adem Korkmaz, Gülbin Kurtay, Esin Kaya, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 15, pp. 7128-7143
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top